L-type voltage-gated Ca2+ channels modulate expression of smooth muscle differentiation marker genes via a rho kinase/myocardin/SRF-dependent mechanism. Wamhoff BR, Bowles DK, McDonald OG, Sinha S, Somlyo AP, Somlyo AV, Owens GK (2004) Circ Res 95: 406-14 Evidence for cytochrome P-450NF, the nifedipine oxidase, being the principal enzyme involved in the bioactivation of aflatoxins in human liver. Shimada T, Guengerich FP (1989) Proc Natl Acad Sci U S A 86: 462-5 Contrasting effects of vasodilators on blood pressure and sodium balance in the hypertension of autonomic failure. Jordan J, Shannon JR, Pohar B, Paranjape SY, Robertson D, Robertson RM, Biaggioni I (1999) J Am Soc Nephrol 10: 35-42 Oxidation of dihydropyridine calcium channel blockers and analogues by human liver cytochrome P-450 IIIA4. Guengerich FP, Brian WR, Iwasaki M, Sari MA, Bäärnhielm C, Berntsson P (1991) J Med Chem 34: 1838-44 Inhibition of human cytochrome P450 3A4 by cholesterol. Shinkyo R, Guengerich FP (2011) J Biol Chem 286: 18426-33 Oxidation of 17 alpha-ethynylestradiol by human liver cytochrome P-450. Guengerich FP (1988) Mol Pharmacol 33: 500-8 The bioelectrical basis and validity of gastrointestinal extracellular slow wave recordings. Angeli TR, Du P, Paskaranandavadivel N, Janssen PW, Beyder A, Lentle RG, Bissett IP, Cheng LK, O'Grady G (2013) J Physiol 591: 4567-79 L-type calcium channels play a critical role in maintaining lens transparency by regulating phosphorylation of aquaporin-0 and myosin light chain and expression of connexins. Maddala R, Nagendran T, de Ridder GG, Schey KL, Rao PV (2013) PLoS One 8: e64676 Nifedipine reduces atherogenesis in cholesterol-fed heterozygous WHHL rabbits. Atkinson JB, Swift LL (1990) Atherosclerosis 84: 195-201 Low kinetic hydrogen isotope effects in the dehydrogenation of 1,4-dihydro-2,6-dimethyl-4-(2-nitrophenyl)-3,5-pyridinedicarboxylic acid dimethyl ester (nifedipine) by cytochrome P-450 enzymes are consistent with an electron/proton/electron transfer mechanism. Guengerich FP (1990) Chem Res Toxicol 3: 21-6 Mechanism-based inactivation of human liver microsomal cytochrome P-450 IIIA4 by gestodene. Guengerich FP (1990) Chem Res Toxicol 3: 363-71 Roles of divalent metal ions in oxidations catalyzed by recombinant cytochrome P450 3A4 and replacement of NADPH--cytochrome P450 reductase with other flavoproteins, ferredoxin, and oxygen surrogates. Yamazaki H, Ueng YF, Shimada T, Guengerich FP (1995) Biochemistry 34: 8380-9 Reconstitution of recombinant cytochrome P450 2C10(2C9) and comparison with cytochrome P450 3A4 and other forms: effects of cytochrome P450-P450 and cytochrome P450-b5 interactions. Yamazaki H, Gillam EM, Dong MS, Johnson WW, Guengerich FP, Shimada T (1997) Arch Biochem Biophys 342: 329-37 Reconstitution premixes for assays using purified recombinant human cytochrome P450, NADPH-cytochrome P450 reductase, and cytochrome b5. Shaw PM, Hosea NA, Thompson DV, Lenius JM, Guengerich FP (1997) Arch Biochem Biophys 348: 107-15 Defective activity of recombinant cytochromes P450 3A4.2 and 3A4.16 in oxidation of midazolam, nifedipine, and testosterone. Miyazaki M, Nakamura K, Fujita Y, Guengerich FP, Horiuchi R, Yamamoto K (2008) Drug Metab Dispos 36: 2287-91 Enhancement of cytochrome P-450 3A4 catalytic activities by cytochrome b(5) in bacterial membranes. Yamazaki H, Nakajima M, Nakamura M, Asahi S, Shimada N, Gillam EM, Guengerich FP, Shimada T, Yokoi T (1999) Drug Metab Dispos 27: 999-1004 Using full probability models to compute probabilities of actual interest to decision makers. Harrell FE, Shih YC (2001) Int J Technol Assess Health Care 17: 17-26
Hints: (1) double-click or double-tap to navigate to a node. (2) Grab a node and move it to arrange the graph.